is retatrutide glp 3 Reta (GLP-3) research product Retatrutide 10-30mg | Triple-Agonist GLP-1

Now, even without insurance, most people in the US with ED can afford a prescription

You May Also Like How to Discuss Weight Loss Medication with Your Doctor Mar 31, 2026 Stopping GLP-1 Medications: How to Protect Your Weight Loss Results Mar 03, 2026 GLP-1 Side Effects: What You May Experience and When to Contact a Doctor Feb 18, 2026 GLP-1 News Updates: New Research Shows Weight Regain After Stopping GLP-1 Medications Feb 04, 2026 Comparing GLP-1 Meds with Other Weight Loss Medications Jan 23, 2026

Side effects are consistent with the GLP-1 class: nausea, vomiting, diarrhea, and constipation are most common and tend to improve over time

The studies were conducted in the United States (2021), Denmark (2022), and Switzerland (2023)